文献速递妇科生殖医学

多囊卵巢综合征患者循环鸢尾素水平的荟萃分析

Circulating irisin in patients with polycystic ovary syndrome: a meta-analysis.
PubMed 文献 · Reprod Biomed Online · 2017-11-22

该荟萃分析纳入8项研究、918例多囊卵巢综合征(PCOS)患者和528名健康对照,评估循环鸢尾素变化。结果显示PCOS患者循环鸢尾素高于总体健康对照(d=0.37,95%CI 0.05至0.70),但与体重指数匹配或年龄和体重指数匹配的对照相比无显著差异;高体重指数PCOS患者循环鸢尾素高于低体重指数者(d=0.36,95%CI 0.16至0.56);PCOS患者正常血糖高胰岛素血症后2小时循环鸢尾素下降幅度大于健康对照(d=-0.32,95%CI -0.53至-0.11)。

要点

  • PCOS患者循环鸢尾素高于总体健康对照(d=0.37,95%CI 0.05至0.70)。
  • 与体重指数匹配或年龄和体重指数匹配的对照相比,循环鸢尾素无显著差异。
  • PCOS患者高胰岛素血症后2小时鸢尾素下降幅度大于健康对照(d=-0.32,95%CI -0.53至-0.11)。

核心结论

  • 调整体重指数后,PCOS患者循环鸢尾素似乎与健康对照相当,但其对高胰岛素血症的反应可能受损。

研究设计与样本

  • 系统检索PubMed、Cochrane Library和Web of Science三个数据库,纳入报告PCOS患者与健康对照比较、或按体重指数分层、或评估鸢尾素对高胰岛素血症反应的研究,共8项研究、918例PCOS患者和528名健康对照,采用随机效应模型计算效应量(Cohen's d及95%CI)。

主要发现

  • PCOS患者循环鸢尾素高于总体健康对照(d=0.37,95%CI 0.05至0.70)。
  • PCOS患者与体重指数匹配或年龄和体重指数匹配的对照相比,循环鸢尾素无显著差异。
  • 高体重指数PCOS患者循环鸢尾素高于低体重指数PCOS患者(d=0.36,95%CI 0.16至0.56)。
  • PCOS患者正常血糖高胰岛素血症后2小时循环鸢尾素下降幅度大于健康对照(d=-0.32,95%CI -0.53至-0.11)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

There is growing interest in exploring circulating (plasma/serum) irisin in polycystic ovary syndrome (PCOS) patients. This meta-analysis aimed to summarize the evidence assessing circulating irisin changes in this population. A systematic search was conducted in three databases: PubMed, Cochrane Library and Web of Science, for studies reporting irisin in PCOS patients compared with healthy controls or stratified by body mass index (BMI), or assessing irisin response to hyperinsulinemia. Effect sizes (Cohen's d with 95% confidence intervals [CI]) were calculated using random-effects models. Eight studies with 918 PCOS patients and 528 healthy controls were included. Results showed that circulating irisin was higher in PCOS patients than in overall healthy controls (d = 0.37, 95% CI 0.05 to 0.70), but not compared with BMI-matched or age- and BMI-matched controls. Circulating irisin was higher in PCOS patients with higher BMI than lower (d = 0.36, 95% CI 0.16 to 0.56). Circulating irisin decreased 2 h later in response to euglycemic hyperinsulinemia in PCOS patients with a larger magnitude than healthy controls (d = -0.32, 95% CI -0.53 to -0.11). In summary, with adjustment for BMI, circulating irisin in PCOS patients seems comparable to healthy controls, but its response to hyperinsulinemia might be impaired.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Cai X, Qiu S, Li L, et al. Circulating irisin in patients with polycystic ovary syndrome: a meta-analysis. Reprod Biomed Online. 2017. PMID: 29217128. doi:10.1016/j.rbmo.2017.10.114

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。